Position in IFRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,092,915
-$920,334 QoQ
Shares Held
7,933,910
0.0% QoQ
Ownership
5.39%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IFRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SUVRETTA CAPITAL MANAGEMENT, LLC holds $2,459,096,047 across 36 Biotechnology names. IFRX ranks #30 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARQT |
Arcutis Biotherapeutics, Inc.
|
12,327,000 | $290,424,120 | |
| 2 | MANE |
Veradermics, Inc
|
4,168,970 | $263,270,455 | |
| 3 | PVLA |
Palvella Therapeutics, Inc.
|
1,153,496 | $143,783,276 | |
| 4 | APLS |
Apellis Pharmaceuticals, Inc.
|
3,518,471 | $141,548,088 | |
| 5 | LEGN |
Legend Biotech Corp
|
7,581,029 | $137,140,814 | |
| 6 | BNTC |
Benitec Biopharma Inc.
|
11,548,351 | $122,989,938 | |
| 7 | CAPR |
Capricor Therapeutics, Inc.
|
3,818,600 | $116,085,440 | |
| 8 | IMTX |
Immatics N.V.
|
11,190,129 | $110,110,869 |
All Filings in IFRX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,092,915 | 7,933,910 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,013,249 | 7,933,910 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $8,688,439 | 6,483,910 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,122,288 | 6,483,910 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,613,588 | 6,483,910 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $14,162,757 | 5,733,910 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $8,772,882 | 5,733,910 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,977,003 | 5,733,910 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $8,830,221 | 5,733,910 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $9,346,273 | 5,733,910 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $17,087,051 | 5,733,910 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $25,573,238 | 5,733,910 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,163,705 | 2,146,240 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,653,344 | 2,146,240 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,666,073 | 2,146,240 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,763,250 | 3,285,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,011,550 | 3,285,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $15,636,600 | 3,285,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $8,508,150 | 3,285,000 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $9,756,450 | 3,285,000 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $12,811,500 | 3,285,000 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||